Home » Emerging technologies » News digest #255 – What is the future of DNA synthesis? + The next generation of natural sweeteners

News digest #255 – What is the future of DNA synthesis? + The next generation of natural sweeteners


SynBioBeta Digest

Your guide to what’s new in synthetic biology

Hi %%first_name%%,

What is the future of DNA synthesis? Check out our overview of the DNA synthesis panel at SynBioBeta 2018, where five experts discussed the latest advancements and trends in the technology, how close we really are to making DNA data storage economically viable, what biosecurity frameworks we should be developing, and, finally, the big opportunity everyone is missing. 

The Future of DNA Synthesis panel at SynBioBeta 2018. Rob Carlson predicts that as enzymatic techniques replace the messy chemistry and other pitfalls, the demand for benchtop synthesizers will rise — we just need to wait and see how long that takes.

In other news, Boston-based Conagen has its sights set on natural sweeteners, which CEO Oliver Yu described in 2017 as “by far” the biggest short-term opportunity space for biobased products in the U.S. Since then, Conagen has achieved important breakthroughs in the production of next-generation stevia leaf sweeteners by fermentation, read more in our article. 

Oliver Yu, CEO of Conagen, at SynBioBeta SF 2017.

What do you think about SynBioBeta’s new website? Take our survey for a chance to win a $100 Amazon gift card. We appreciate your suggestions as we strive to provide the most valuable news resource for the synthetic biology industry.

Happy 2019!

Latest news

Vedanta Biosciences raises $27M to advance microbiome-derived products

Read more →

Beverly pharma robotics company names new CEO

Read more →

Living Architecture: Investigating the interface between biology and architecture

Read more →

The case for ‘blueprints’ in scientific communication

Read more →

Flu season: Bay Area scientists working toward ‘post-influenza world’

Read more →

7 big biotech ideas for 2019

Read more →

More reads

More reads

Emerging technologies: Synthetic biology, a revolution across all industries

Getting yeast to make artificial sweets (ACS)

How synthetic biology could treat celiac disease (ACSH)

Novo Nordisk purchases Berkeley Lights’ Beacon® Optofluidic platform for cell line development and antibody discovery (Press release)

Zymergen appoints Jens Peter Clausen as Senior Vice President, Global Manufacturing (Press release)

Evonetix establishes scientific advisory board (Press release)

Expanded Centre for Synthetic Biology launches at Imperial

Canada SynBio 2019 Pitch Competition: apply to pitch for up to $25,000 in prize money

Arbor Biosciences aims to fill CRISPR toolbox with targeted sequencing technology (Genome Web)

How can we engineer the human body to survive on Mars … and beyond? (NPR)

Synthetic biology goes to space: Experiment sends engineered plants to International Space Station

Who's hiring?

Who’s hiring?

Software Engineer – Back-end: Serotiny

Synthetic Biology Research Associate: LanzaTech

Scientist, Strain Engineering at 64-x

Head of Finance (VP/SVP level): Ginkgo Bioworks

Careers in Protein Engineering at Codexis

Senior Software Engineer: CATALOG

Head of Bioprocess: C16 Biosciences

Engineering Lead: Ansa Biotechnologies

Scientist, Microorganism Engineering at 64-x

Scientist: CATALOG

Mammalian Synthetic Biology – Protein Engineer: Serotiny

Mechanical Engineer: CATALOG

Synthetic and Microbial Biologist: C16 Biosciences

Feature your job here →


Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Editor’s picks